Polymyxin B Sulfate + ChloramphenicolThird Party Manufacturing in India

Polymyxin B Sulfate + Chloramphenicol works via a synergistic dual-pathway mechanism to eliminate pathogenic bacterial populations in the ocular or otic microenvironments. Polymyxin B Sulfate behaves like a cationic detergent, targeting and binding to phospholipids in the outer membranes of Gram-negative bacteria, disrupting osmotic integrity and causing cellular lysis. Simultaneously, Chloramphenicol penetrates the cell wall of both Gram-positive and Gram-negative organisms, binding reversibly to the 50S ribosomal subunit to arrest peptidyl transferase activity and stop bacterial protein synthesis. Unlike single-class antibiotics, this combination overcomes individual resistance barriers by halting cell wall function and internal translation concurrently. It is highly effective and well-tolerated.

Therapeutic Uses

• Bacterial Conjunctivitis: Eradicates acute superficial infections of the conjunctiva caused by susceptible microbial strains.
• Otitis Externa: Treats localized infections of the external ear canal while reducing risks of cellular spreading.
• Prophylactic Ocular Care: Prevents bacterial colonization following minor trauma or foreign body removal from the eye.

Why Manufacturers Choose Polymyxin B Sulfate + Chloramphenicol

This formulation is widely commercialized across primary healthcare networks due to its definitive broad-spectrum efficacy and low cost per unit. Celesta coordinates with modern, WHO-GMP certified partner processing plants to execute precise sterile filtration and filled-vial integrity protocols. Transitioning your Polymyxin B Sulfate + Chloramphenicol third party manufacturing in India to our platform ensures your product lines comply with the chemical standards of CAS number 1405-20-5 and maintain excellent clinical viability.